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AbstrACt
Objectives To measure changes in length of stay following 
total knee and hip replacement (TKR and THR) between 
1997 and 2014 and estimate the impact on hospital 
reimbursement, all else being equal. Further, to assess 
the degree to which observed trends can be explained by 
improved efficiency or changes in patient profiles.
Design Cross-sectional study using routinely collected 
data.
setting National Health Service primary care records from 
1995 to 2014 in the Clinical Practice Research Datalink 
were linked to hospital inpatient data from 1997 to 2014 in 
Hospital Episode Statistics Admitted Patient Care.
Participants Study participants had a diagnosis of 
osteoarthritis or rheumatoid arthritis.
Interventions Primary TKR, primary THR, revision TKR 
and revision THR.
Primary outcome measures Length of stay and hospital 
reimbursement.
results 10 260 primary TKR, 10 961 primary THR, 
505 revision TKR and 633 revision THR were included. 
Expected length of stay fell from 16.0 days (95% CI 14.9 
to 17.2) in 1997 to 5.4 (5.2 to 5.6) in 2014 for primary TKR 
and from 14.4 (13.7 to 15.0) to 5.6 (5.4 to 5.8) for primary 
THR, leading to savings of £1537 and £1412, respectively. 
Length of stay fell from 29.8 (17.5 to 50.5) to 11.0 (8.3 
to 14.6) for revision TKR and from 18.3 (11.6 to 28.9) 
to 12.5 (9.3 to 16.8) for revision THR, but no significant 
reduction in reimbursement was estimated. The estimated 
effect of year of surgery remained similar when patient 
characteristics were included.
Conclusions Length of stay for joint replacement fell 
substantially from 1997 to 2014. These reductions 
have translated into substantial savings. While patient 
characteristics affect length of stay and reimbursement, 
patient profiles have remained broadly stable over time. 
The observed reductions appear to be mostly explained by 
improved efficiency.
IntrODuCtIOn 
Knee and hip replacements relieve pain 
and improve function for individuals with 
end-stage arthritis, leading to substantial 
gains in an individual’s quality of life.1 2 The 
procedures are a cost-effective use of health-
care resources, with their costs justified by 
the expected health gains for the individuals 
receiving them.1 2 Rates of joint replacement 
grew substantially between 1991 and 2006 in 
the UK.3 Demand is projected to continue 
to rise in the USA up to 2030 and, in turn, 
the number of revision procedures is also 
expected to increase.4 
Satisfying rising demand will require either 
additional resources, which is unlikely given 
current funding constraints, or reducing the 
cost of the procedures. Length of stay is a key 
component of the overall cost of joint replace-
ment. Greater efficiency should reduce the 
expected length of stay for an individual 
requiring surgery and lead to cost-savings, all 
else being equal. If patient health outcomes 
are not compromised in the process, greater 
efficiency would make joint replacement a 
more cost-effective procedure.
Length of stay following joint replacement 
has fallen substantially.5–11 Although such 
reductions may be explained by improved 
strengths and limitations of this study
 ► Routinely collected data provided real-world 
information on trends in length of stay following 
primary knee and hip replacement and revision 
procedures.
 ► Patient characteristics were controlled for to assess 
whether trends in length of stay and associated 
hospital reimbursement were explained by changes 
in patient characteristics or improved efficiency.
 ► Codes used to identify diagnoses of osteoarthritis 
have not been fully evaluated.
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efficiency, they may also be explained by changes in 
patient profiles over time. As patient characteristics are 
likely to influence length of stay, changes in these char-
acteristics would partially explain the observed changes 
in stay length. Individuals at greater risk of poor health 
outcomes, due to either preoperative comorbidities or 
postoperative complications, can be expected to have 
longer stays. Social determinants can also be expected to 
influence length of stay.
We assessed the extent to which length of stay following 
joint replacement decreased in the English National 
Health Service (NHS) from 1997 to 2014, and whether 
such changes have been translated into reduced reim-
bursement to hospitals, all else being equal. We consid-
ered the degree to which observed changes can be 
explained by improved efficiency or changes in patient 
profiles.
MethODs
study design
Individuals with a diagnosis of osteoarthritis (OA) or 
rheumatoid arthritis (RA) were identified from primary 
care records. Linked hospital records were used to 
identify the procedures of interest following diagnosis: 
primary total knee replacement (TKR), primary total hip 
replacement (THR), revision TKR and revision THR. 
Length of stay and hospital reimbursement for these 
surgeries were calculated. Trends in length of stay over 
time were assessed using univariable generalised linear 
models. How such reductions have translated into lower 
hospital reimbursement, all else being equal, was assessed 
by examining trends in reimbursement, at current rates, 
in a similar manner. Patient characteristics were added as 
explanatory variables to the models to consider whether 
trends were explained by changes in efficiency or changes 
in patient profiles.
setting
Primary care records were derived from the Clinical Prac-
tice Research Datalink (CPRD). CPRD contains medical 
records and demographic details for around 7% of the 
UK population, with those included representative of the 
general population.12 A subset of practices within CPRD 
were linked to inpatient hospital records, provided by 
Hospital Episode Statistics Admitted Patient Care (HES 
APC). HES APC contains data on all NHS hospital admis-
sions in England, with each uninterrupted inpatient stay 
at one hospital recorded as a spell (the time a patient 
spent in a particular hospital).13 The CPRD extract used to 
identify diagnoses began in January 1995. The HES APC 
extract used to identify events of interest began in April 
1997. Linked data from both databases were extracted up 
to March 2014.
Participants
We extracted CPRD records for individuals with a diag-
nosis of either OA or RA. Study participants were identified 
separately for procedures relating to the knee and hip. 
For procedures relating to the knee, CPRD records were 
extracted for those individuals with a diagnosis recorded 
for RA or knee OA. For procedures relating to the hip, 
records were extracted for individuals with a diagnosis of 
RA or hip OA.
Some individuals had diagnostic codes for both RA and 
OA. It was not possible to determine which of their diag-
noses drove the decision for joint replacement. The need 
for a joint replacement for those with RA is often depen-
dent on the development of secondary OA. Diagnosis 
of RA was therefore taken as the index diagnosis from 
which follow-up started when patients had both diagnoses 
recorded.
CPRD records were then linked with HES APC data 
and procedures of interest after the index diagnosis were 
identified. Only the first instance of each procedure for 
an individual was included in the analysis, and any bilat-
eral procedures were excluded. Although no individuals 
contributed multiple records of the same surgery, an indi-
vidual could provide data on multiple procedures.
Variables
Diagnoses of RA, knee OA and hip OA were identified 
using clinical read codes within CPRD. Events of interest 
(TKR, TKR revision, THR and THR revision) were iden-
tified using operating procedure codes (OPCS) in HES 
APC.
The date of a procedure recorded in HES APC was used 
to identify the year of surgery and, given an individual’s 
year of birth recorded in CPRD, age at surgery. Gender 
was recorded in CPRD. Diagnosis codes in HES APC were 
used to identify diseases included in the Royal College of 
Surgeons (RCS) Charlson score, a measure of comorbid-
ities, and to calculate the overall summary score (0, 1, 2 
or 3+).14 Index of Multiple Deprivation (IMD) quintiles, 
a measure of socioeconomic status (with IMD quintile 5 
implying the highest level of deprivation), were derived 
from CPRD.
Length of stay was recorded within HES APC by days for 
the spell in which a procedure occurred. Hospital spells 
were assigned to Healthcare Resource Groups (HRGs), 
which group clinically similar treatments using common 
levels of healthcare resources. The 2017/2018 draft prices 
were used to estimate hospital reimbursement of spells 
based on the HRG, the method of admission (elective or 
non-elective), the expected physiotherapy cost and any 
stay longer than the trim-point, which is the upper limit 
of length of stay incorporated in the HRG cost. While 
variation between individuals’ hospital reimbursement 
were influenced by HRG codes and type of admission, 
high estimates were driven primarily by stays longer than 
the trim-point. Changes in reimbursement over time, 
therefore, reflect the effect of changing length of stay 
on reimbursement to hospitals from the NHS at current 
levels, not the accounting costs incurred by hospitals 
or historical reimbursement rates. Secondary diagnosis 
codes that were ineligible for grouping were dropped 
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from the record. Reimbursement was classified as missing 
if the primary diagnosis or any other variable required for 
the grouper software was ineligible.
statistical methods
Trends in length of stay and hospital reimbursement 
over time for each procedure were assessed using univari-
able regression models that used the year of surgery as 
the explanatory factor. Multivariable regressions that 
included patient characteristics were also specified. We 
compared the estimated effect of year of surgery on length 
of stay and hospital reimbursement with and without 
patient characteristics to determine the extent to which a 
trend over time could be explained by change in patient 
characteristics or improvements in efficiency. A similar 
approach has previously been used to assess whether vari-
ations in length of stay between types of providers are due 
to differences in efficiency or patient selection.15
As both length of stay and hospital reimbursement are 
non-negative and right-skewed, generalised linear models 
with a gamma distribution and a log-link were specified.16 
For continuous variables, non-linearity was incorporated 
using restricted cubic splines. Interactions between year 
and patient characteristics were tested for in the multi-
variable model through a comparison, using analysis of 
variance, of models with and without interaction terms. 
The Bayesian information criterion (BIC) was used to 
decide whether to specify a variable’s relationship as 
non-linear and, if included, how many knots to include. 
Compared with the Akaike information criterion, BIC 
favours parsimony and has been recommended for 
explanatory models.17
Year of surgery, diagnosis (RA or OA), age, gender, 
RCS Charlson score and IMD quintile were included as 
explanatory variables in each of the multivariable models. 
The code for RA was omitted from calculations of the 
RCS Charlson score as RA was specified as a separate vari-
able. The estimated effect of the RCS Charlson score is 
that of comorbidities aside from RA. The two highest RCS 
Charlson score categories, 2 and 3+, were combined into 
the category 2+ as there were few scores of 3 or more.
The only explanatory variable with missing data was 
the IMD quintile, which was missing for nine TKR and 
seven THR; these individuals were omitted from all 
regressions. There were no missing data for length of 
stay. Reimbursement estimates could not be calculated 
for 2.3% of the spells for which the HRG grouper did not 
produce a valid HRG code. Spells without HRG codes 
were dropped from the regressions on hospital reim-
bursement, but were included in the analysis of length 
of stay.
Data analysis was primarily undertaken in R V.3.3.1,18 
using dplyr19 for data manipulation, rms20 for fitting 
regression models and ggplot221 to produce plots. 
HRG4+ codes were derived using the 2015/2016 Refer-
ence Costs Grouper.
results
study participants
Records from 21 128 patients with OA or RA were included 
in the analysis, with 10 260 undergoing primary TKR, 
10 961 primary THR, 505 TKR revision and 633 THR revi-
sion in the study period. Inclusion of study participants is 
described in a flow chart in figure 1. Around 2% of indi-
viduals had diagnoses of both OA and RA. RA was taken 
as the index diagnosis for these individuals.
Figure 1 Study inclusion flow chart. CPRD, Clinical Practice Research Datalink; HES APC, Hospital Episode Statistics 
Admitted Patient Care; OA, osteoarthritis; RA, rheumatoid arthritis; THR, total hip replacement; TKR, total knee replacement. 
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Individuals’ characteristics at the time of surgery 
are described in table 1 and are stratified by year of 
surgery in the online supplementary appendix 1. Age, 
gender and socioeconomic status, measured by IMD 
quintile, remained relatively stable over the study 
period. While the proportion of patients with a diag-
nosis of RA fell over time, the number of comorbidities 
at surgery, as measured by the RCS Charlson score, 
increased.
trends in expected length of stay and hospital reimbursement 
over time
Observed length of stay and hospital reimbursement by 
year of surgery are detailed in the online supplementary 
Table 1 Patient characteristics by procedure
Primary TKR Primary TKR Revision TKR Revision THR
No of study participants 10 260 10 961 505 633
Age (mean (SD)) 70.01 (9.24) 68.93 (10.53) 69.43 (9.93) 70.34 (10.91)
Gender: male (n (%)) 4426 (43.1) 4525 (41.3) 233 (46.1) 264 (41.7)
Year of surgery (median (IQR)) 2009 (2006, 2011) 2008 (2005, 2011) 2009 (2007, 2011) 2009 (2006, 2011)
Diagnoses recorded in CPRD
  Rheumatoid arthritis (n (%)) 851 (8.3) 639 (5.8) 65 (12.9) 92 (14.5)
Diagnoses recorded in HES APC
  Myocardial infarction (n (%)) 138 (1.3) 140 (1.3) 6 (1.2) 14 (2.2)
  Congestive cardiac failure (n (%)) 96 (0.9) 137 (1.2) 8 (1.6) 14 (2.2)
  Peripheral vascular disease (n (%)) 101 (1.0) 102 (0.9) 10 (2.0) 8 (1.3)
  Cerebrovascular disease (n (%)) 54 (0.5) 56 (0.5) 3 (0.6) 5 (0.8)
  Dementia (n (%)) 25 (0.2) 37 (0.3) 0 (0.0) 10 (1.6)
  Chronic pulmonary disease (n (%)) 1091 (10.6) 998 (9.1) 58 (11.5) 55 (8.7)
  Rheumatological disease (n (%)) 593 (5.8) 474 (4.3) 38 (7.5) 50 (7.9)
  Liver disease (n (%)) 20 (0.2) 22 (0.2) 0 (0.0) 5 (0.8)
  Diabetes mellitus (n (%)) 991 (9.7) 755 (6.9) 56 (11.1) 45 (7.1)
  Haemiplegia or paraplegia (n (%)) 18 (0.2) 17 (0.2) 4 (0.8) 5 (0.8)
  Renal disease (n (%)) 202 (2.0) 235 (2.1) 11 (2.2) 20 (3.2)
  Any malignancy (n (%)) 78 (0.8) 97 (0.9) 7 (1.4) 9 (1.4)
  Metastatic solid tumour (n (%)) 6 (0.1) 10 (0.1) 1 (0.2) 2 (0.3)
  AIDS HIV infection (n (%)) 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0)
RCS Charlson score (n (%))
  0 7443 (72.5) 8413 (76.8) 342 (67.7) 455 (71.9)
  1 2302 (22.4) 2110 (19.3) 130 (25.7) 124 (19.6)
  2 437 (4.3) 353 (3.2) 29 (5.7) 45 (7.1)
  3+ 78 (0.8) 85 (0.8) 4 (0.8) 9 (1.4)
IMD quintiles (n (%))
  1 2330 (22.7) 2779 (25.4) 128 (25.3) 208 (32.9)
  2 2487 (24.2) 2794 (25.5) 120 (23.8) 155 (24.5)
  3 2383 (23.2) 2479 (22.6) 117 (23.2) 127 (20.1)
  4 1930 (18.8) 1923 (17.5) 105 (20.8) 84 (13.3)
  5 1121 (10.9) 980 (8.9) 35 (6.9) 59 (9.3)
  Missing 9 (0.1) 6 (0.1) 0 (0.0) 0 (0.0)
Ethnicity (n (%))
  Non-White 240 (2.3) 60 (0.5) 15 (3.0) 6 (0.9)
  White 9073 (88.4) 9643 (88.0) 460 (91.1) 575 (90.8)
  Missing 947 (9.2) 1258 (11.5) 30 (5.9) 52 (8.2)
CPRD, Clinical Practice Research Datalink; HES APC, Hospital Episode Statistics Admitted Patient Care; IMD, Index of Multiple Deprivation; 
RCS, Royal College of Surgeons; THR, total hip replacement; TKR, total knee replacement.
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appendix 1. The estimated effects of year of surgery 
on length of stay from univariable regressions are 
presented in figure 2. Expected length of stay fell from 
16.0 days (95% CI 14.9 to 17.2) in 1997 to 5.4 (5.2 to 
5.6) in 2014 for primary TKR, from 14.4 (13.7 to 15.0) 
to 5.6 (5.4 to 5.8) for primary THR, from 29.8 (17.5 to 
50.5) to 11.0 (8.3 to 14.6) for revision TKR and from 
18.3 (11.6 to 28.9) to 12.5 (9.3 to 16.8) for revision 
THR. Including patient characteristics in the regres-
sion models had little effect on the association between 
year of surgery and length of stay and hospital reim-
bursement, as shown in table 2. For example, multivari-
able adjustment for patient characteristics changed the 
expected reduction in length of stay for primary THR 
from 5% (relative effect (RE) 0.95 (95% CI 0.94 to 
0.95)) to 6% per year (RE 0.94 (95% CI 0.94 to 0.95)).
Estimated trends in hospital reimbursement from 
univariable regressions were broadly similar to those 
estimated for length of stay (figure 3). Expected mean 
hospital reimbursement fell from £7634 (£7464 to 
£7808) for hospital stays in 1997 to £6097 (£6016 to 
£6179) for 2014 stays for primary TKR, from £7300 
(£7187 to £7414) to £5888 (£5827 to £5949) for primary 
THR, from £9088 (£7727 to £10 689) to £7296 (£6717 
to £7926) for revision TKR and from £7655 (£6385 to 
£9177) to £7564 (£6743 to £8485) for revision THR. 
Including patient characteristics in the regression 
models did not remove the estimated association 
between year of surgery and hospital reimbursement, 
as shown in table 3. For example, the expected reduc-
tion in hospital reimbursement for revision TKR was 
1% per year (RE: 0. 99 (95% CI 0.97 to 1.00)) in the 
unadjusted model and 1% per year (RE: 0. 99 (95% CI 
0.98 to 1.00)) in the multivariable model.
Impact of patient characteristics on expected length of stay 
and hospital reimbursement
Tables 2 and 3 detail the relative effects of patient char-
acteristics on length of stay and hospital reimburse-
ment from the fully specified models. No interactions 
between year of surgery and patient characteristics were 
identified. Higher age at surgery was associated with 
longer stays for each procedure. Where the effect of age 
was non-linear, its impact was more pronounced among 
older patients. Holding all other explanatory variables 
at their average, expected length of stay increased from 
5.7 (5.5 to 5.9) for a 55-year-old to 9.1 (8.7 to 9.5) for 
an 85-year-old undergoing primary TKR, from 6.2 (5.9 
to 6.4) to 10.6 (10.1 to 11.0) for primary THR, from 
9.6 (6.5 to 14.1) to 14.4 (9.5 to 21.8) for revision TKR 
and from 12.4 (9.4 to 16.3) to 27.3 (21.0 to 35.5) for 
revision THR. Similar upward trends were estimated 
for hospital reimbursement for each of the procedures 
of interest. With other explanatory variables held at 
their average value, expected reimbursement increased 
from £5856 (£5791 to £5923) for a 55-year-old to £6553 
(£6471 to £6636) for an 85-year-old undergoing primary 
TKR, from £5792 (£5734 to £5850) to £6596 (£6520 to 
£6672) for primary THR, from £6409 (£5811 to £7069) 
to £7691 (£6976 to £8480) for revision TKR and from 
£8071 (£7292 to £8934) to £10 269 (£9315 to £11 320) 
for revision THR. Plots of the partial effect of age on 
length of stay and hospital reimbursement are provided 
in the online supplementary appendix 1.
Figure 2 Trends in length of stay. Estimated effect of year of surgery on length of stay (in days). THR, total hip replacement; 
TKR, total knee replacement.
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DIsCussIOn
Principal findings
Length of stay for primary TKR and primary THR fell 
significantly in the English NHS between 1997 and 2014. 
Expected length of stay fell by 11 days for primary TKR 
and 9 days for primary THR. The trajectory of the fall 
in expected length of stay was estimated as linear for 
primary THR, but had slowed somewhat towards the end 
of the study period for primary TKR. Length of stay also 
fell significantly for revision TKR, by 19 days between 
1997 and 2014. Although a drop of 6 days was estimated 
for revision THR, this fall was not statistically significant.
Reductions is length of stay have, all else being equal, 
led to significant reductions in hospital reimbursement. 
Reimbursement was reduced by £1537 for primary TKR 
and £1412 for primary THR than otherwise would have 
been the case. The trajectories of these reductions in 
reimbursement were broadly in line with those of length 
of stay. The estimated reductions in reimbursement due 
to reduced length of stay for the revision procedures, 
£1792 for revision TKR and £91 for revision THR, were 
not statistically significant.
Age at surgery was associated with increased length 
of stay and reimbursement for each procedure with, in 
general, greater increases among older patients. RA and 
other comorbidities were associated with significantly 
higher length of stay and hospital reimbursement. Lower 
socioeconomic status was associated with a significant 
increase in length of stay and reimbursement for primary 
procedures. Male gender was associated with significantly 
shorter stays for primary procedures.
While the age, gender and socioeconomic status of those 
receiving joint replacement and revision surgery remained 
stable over time, individuals undergoing surgery had more 
comorbidities in more recent years, although the propor-
tion diagnosed with RA fell. Controlling for patient char-
acteristics had little effect on the association between year 
of surgery and length of stay or associated hospital reim-
bursement. These results imply that the downward trends 
in length of stay and associated hospital reimbursement are 
generally explained by increased efficiency.
study findings in context
Previous studies have also found length of stay to have 
fallen over recent decades following TKR and THR.5–11 
The downward trends in length of stay appear to be 
primarily due to increased efficiency rather than changes 
in patient characteristics.
A key driver of the efficiency gains in joint replace-
ment has likely been a move towards ‘fast-track’ arthro-
plasty.22 Enhanced recovery programmes (ERPs) have 
become increasingly prominent in orthopaedic surgery, 
aiming to standardise routine perioperative care, reduce 
length of hospital stay and promote rapid recovery.23 
These programmes have been found to reduce length of 
stay for a range of surgical procedures,24 including knee 
and hip replacement.25 The implementation of ERPs has 
been associated with either equivalent23 26 or improved 
health outcomes,25 and there is little evidence that ERPs 
lead to an increase in readmission rates.24 27
While ERPs have gained prominence, there remains 
scope for further implementation. As demonstrated in our 
study, both older age at surgery and comorbidities are asso-
ciated with higher length of stay following TKR and THR. 
ERPs have been demonstrated to be appropriate for such 
patients, and the reductions in length of stay are, in fact, 
Figure 3 Trends in hospital reimbursement. Estimated effect of year of surgery on hospital reimbursement (at 2016/2017 rates 
in GBP). THR, total hip replacement; TKR, total knee replacement.
8 Burn E, et al. BMJ Open 2018;8:e019146. doi:10.1136/bmjopen-2017-019146
Open Access 
Ta
b
le
 3
 
M
ul
tiv
ar
ia
b
le
 r
eg
re
ss
io
ns
 fo
r 
ho
sp
ita
l r
ei
m
b
ur
se
m
en
t
P
ri
m
ar
y 
T
K
R
 (R
E
 (9
5%
 C
I))
P
ri
m
ar
y 
T
H
R
 (R
E
 (9
5%
 C
I))
R
ev
is
io
n 
T
K
R
 (R
E
 (9
5%
 C
I))
R
ev
is
io
n 
T
H
R
 (R
E
 (9
5%
 C
I))
U
na
d
ju
st
ed
A
d
ju
st
ed
U
na
d
ju
st
ed
A
d
ju
st
ed
U
na
d
ju
st
ed
A
d
ju
st
ed
U
na
d
ju
st
ed
A
d
ju
st
ed
Ye
ar
 o
f s
ur
ge
ry
0.
98
 (0
.9
7 
to
 0
.9
8)
0.
98
 (0
.9
7 
to
 0
.9
8)
0.
98
 (0
.9
8 
to
 0
.9
8)
0.
98
 (0
.9
8 
to
 0
.9
8)
0.
99
 (0
.9
7 
to
 1
.0
0)
0.
99
 (0
.9
8 
to
 1
.0
0)
1.
02
 (0
.9
9 
to
 1
.0
4)
1.
02
 (1
.0
0 
to
 1
.0
4)
Ye
ar
 o
f s
ur
ge
ry
*
1.
02
 (1
.0
1 
to
 1
.0
3)
1.
02
 (1
.0
1 
to
 1
.0
3)
1.
01
 (1
.0
1 
to
 1
.0
1)
1.
01
 (1
.0
1 
to
 1
.0
1)
0.
97
 (0
.9
5 
to
 1
.0
0)
0.
97
 (0
.9
4 
to
 0
.9
9)
Ye
ar
 o
f s
ur
ge
ry
* 
0.
95
 (0
.9
1 
to
 0
.9
9)
0.
94
 (0
.9
1 
to
 0
.9
8)
A
ge
1.
00
 (1
.0
0 
to
 1
.0
0)
1.
00
 (1
.0
0 
to
 1
.0
0)
1.
01
 (1
.0
0 
to
 1
.0
1)
1.
01
 (1
.0
0 
to
 1
.0
1)
A
ge
*
1.
00
 (1
.0
0 
to
 1
.0
0)
1.
00
 (1
.0
0 
to
 1
.0
1)
A
ge
* 
1.
02
 (1
.0
0 
to
 1
.0
3)
G
en
d
er
: m
al
e
1.
01
 (1
.0
0 
to
 1
.0
1)
0.
99
 (0
.9
8 
to
 1
.0
0)
0.
99
 (0
.9
2 
to
 1
.0
7)
0.
93
 (0
.8
6 
to
 1
.0
0)
D
ia
gn
os
is
: R
A
1.
04
 (1
.0
3 
to
 1
.0
5)
1.
03
 (1
.0
1 
to
 1
.0
4)
1.
37
 (1
.2
3 
to
 1
.5
3)
1.
13
 (1
.0
2 
to
 1
.2
6)
R
C
S
 C
ha
rls
on
 
sc
or
e†
 
 
 0
R
ef
R
ef
R
ef
R
ef
 
 1
1.
05
 (1
.0
5 
to
 1
.0
6)
1.
03
 (1
.0
2 
to
 1
.0
4)
1.
04
 (0
.9
6 
to
 1
.1
4)
1.
10
 (1
.0
0 
to
 1
.2
1)
 
 2+
1.
13
 (1
.1
1 
to
 1
.1
5)
1.
10
 (1
.0
8 
to
 1
.1
2)
1.
31
 (1
.1
0 
to
 1
.5
8)
1.
13
 (0
.9
7 
to
 1
.3
2)
IM
D
 q
ui
nt
ile
s
 
 1
R
ef
R
ef
R
ef
R
ef
 
 2
1.
02
 (1
.0
1 
to
 1
.0
3)
1.
00
 (0
.9
9 
to
 1
.0
1)
1.
05
 (0
.9
5 
to
 1
.1
6)
0.
92
 (0
.8
4 
to
 1
.0
2)
 
 3
1.
02
 (1
.0
1 
to
 1
.0
3)
1.
00
 (0
.9
9 
to
 1
.0
1)
1.
06
 (0
.9
6 
to
 1
.1
8)
0.
88
 (0
.8
0 
to
 0
.9
8)
 
 4
1.
01
 (1
.0
0 
to
 1
.0
2)
1.
01
 (1
.0
0 
to
 1
.0
2)
1.
08
 (0
.9
7 
to
 1
.2
0)
0.
91
 (0
.8
1 
to
 1
.0
3)
 
 5
1.
03
 (1
.0
2 
to
 1
.0
4)
1.
02
 (1
.0
1 
to
 1
.0
3)
0.
94
 (0
.8
1 
to
 1
.1
0)
0.
94
 (0
.8
2 
to
 1
.0
8)
E
xp
la
na
to
ry
 fa
ct
or
s’
 r
el
at
iv
e 
ef
fe
ct
 (R
E
) o
f d
ia
gn
os
is
 o
n 
ho
sp
ita
l r
ei
m
b
ur
se
m
en
t 
(a
t 
20
16
/2
01
7 
ra
te
s 
in
 G
B
P
) w
ith
 9
5%
 C
I f
ro
m
 u
ni
va
ria
b
le
 a
nd
 m
ul
tiv
ar
ia
b
le
 r
eg
re
ss
io
ns
.
*I
nd
ic
at
es
 k
no
ts
 fo
r 
re
st
ric
te
d
 c
ub
ic
 s
p
lin
e.
† 
R
he
um
at
oi
d
 a
rt
hr
iti
s 
(R
A
) c
od
es
 w
er
e 
om
itt
ed
 fr
om
 t
he
 c
al
cu
la
tio
n 
of
 t
he
 R
oy
al
 C
ol
le
ge
 o
f S
ur
ge
on
s 
(R
C
S
) C
ha
rls
on
 s
co
re
 a
nd
 g
ro
up
s 
2 
an
d
 3
+
 c
om
b
in
ed
 in
to
 2
+
.
IM
D
, I
nd
ex
 o
f M
ul
tip
le
 D
ep
riv
at
io
n;
 T
H
R
, t
ot
al
 h
ip
 r
ep
la
ce
m
en
t;
 T
K
R
, t
ot
al
 k
ne
e 
re
p
la
ce
m
en
t.
 9Burn E, et al. BMJ Open 2018;8:e019146. doi:10.1136/bmjopen-2017-019146
Open Access
greater than for younger patients with fewer comorbidi-
ties.28 Greater implementation of ERPs among such groups 
can, then, be expected to lead to further reductions in 
length of stay following joint replacement and additional 
cost-savings from the NHS perspective.
In the UK, government policy has also encouraged the 
use of specialist centres for joint replacement, and this has 
likely also contributed to the observed reductions in length 
of stay. Patients in specialised centres typically have lower 
length of stay.9 This difference is not only due to patient 
selection as even after controlling for differences in the 
characteristics of those undergoing surgery in different 
centres, length of stay following THR is lower when surgery 
is undertaken at a specialist treatment centre.15
As would be expected, the reductions in length of stay 
translate into reduced reimbursement to hospitals than 
otherwise would be the case. This has also been seen in 
the USA where, although the overall costs for joint replace-
ment have risen, falling length of stay has attenuated the 
increase.29 30
As observed here, the age and gender of those under-
going surgery have been relatively stable between 1991 and 
2006.3 Older age at surgery, particularly those over 80,6 31 
and of lower income31 are both associated with longer stays. 
While gender has typically not been found to have an effect 
on length of stay6 or costs,32 being a woman was associ-
ated with longer stays following TKR in one study.31 Over 
the study period, individuals appear to have an increasing 
number of comorbidities at the time of surgery for all of 
the procedures considered. This trend has previously been 
reported in the USA.5 7 30 Comorbidities have been associ-
ated with longer hospital stays and greater costs following 
primary joint replacement.31 32 The proportion of those 
undergoing primary TKR with a diagnosis RA though fell 
over time in this study. This trend has also previously been 
reported and is likely explained by therapeutic advances, 
such as the introduction of biologic therapies.33 The rela-
tive impact of RA on length of stay and costs is not well 
known, but the increases estimated here may be explained 
by greater morbidity before surgery and the use of medica-
tions such as steroids and immunosuppressants.
strength and limitations of this study
Routinely collected data are not collected primarily to 
inform research, leading to a number of possible limita-
tions. Coding accuracy is of particular concern. While 
the diagnosis of RA34 and the coding of primary TKR and 
primary THR35 have previously been validated in CPRD 
and HES APC, respectively, OA coding has not been thor-
oughly evaluated. If those misclassified as not having an OA 
diagnosis differed systematically from those with a recorded 
OA diagnosis, the external validity of our results may be 
affected.
A number of patient characteristics were controlled for 
to assess whether trends in length of stay and reimburse-
ment were explained by changes in patient characteristics 
or improved efficiency. These included age, gender, comor-
bidities and socioeconomic status. However, other patient 
characteristics may have changed over time and influenced 
length of stay or reimbursement. Moreover, the changes in 
reported comorbidities may reflect changes in data capture 
over time.
A further limitation of this study is that we only exam-
ined the length of stay and hospital reimbursement of the 
spell for each individual’s first recorded primary and revi-
sion procedure. This may have led to an underestimation 
of the total reimbursement to hospitals. In particular, revi-
sion procedures can have multiple stages and subsequent 
revision procedures may be required, which may lead to a 
higher overall hospital reimbursement than reported here. 
Furthermore, readmissions have not been included in the 
study. If reduced length of stay has been accompanied by 
an increase in the number of readmissions, then the reduc-
tions in resource use will have been overstated.
The primary strength of this study is that, despite poten-
tial concerns around coding accuracy, it was informed 
by routinely collected data, which provided real-world 
evidence of trends in length of stay. Sample sizes were large, 
particularly for primary TKR and primary THR, allowing 
a thorough analysis of trends over time, and the data were 
representative of the experience of the NHS in England.
The costs estimated here reflect reimbursement to hospi-
tals by the NHS. By using current reimbursement rates, it 
has been possible to consider how changes in length of stay 
have translated into changes in reimbursement, all else 
being equal. However, trends in overall reimbursement 
likely follow a different trend given changes in other factors, 
such as the prices of implants. In addition, the accounting 
costs incurred by hospitals likely differ to the reimbursement 
received and have not been assessed in this study. Trends in 
the costs incurred by hospitals may differ, for example, if 
they are less sensitive to changes in length of stay.
Policy implications and areas for future research
Expected length of stay associated with TKR and THR fell 
significantly between 1997 and 2014. This appears to be 
due to improved efficiency rather than changes in patient 
profiles. The reductions in length of stay have led, all else 
being equal, to reduced hospital reimbursement. If health 
outcomes have not worsened, reductions in length of stay 
will have improved the cost-effectiveness of joint replace-
ment relative to what otherwise would have been the case.
With stretched healthcare budgets, further improvements 
in efficiency will likely be necessary for supply to keep pace 
with the rising demand for joint replacement procedures. 
Additional research into the drivers of the efficiency gains 
identified in this study would help inform future policy 
decisions.
Acknowledgements The authors would like to thank Miss Susan Thwaite 
(National Rheumatoid Arthritis Society) for her role as the patient and public 
representative and her role in the study steering committee. We also thank Dr 
Jennifer A de Beyer of the Centre for Statistics in Medicine, University of Oxford, for 
English language editing. 
Contributors EB, CJE, DWM, AS, CC, NKA, RPV and DPA all made substantial 
contributions to conception and design of the study. EB, RPV and DPA undertook the 
statistical analysis. EB, RPV and DPA drafted the manuscript with CJE, DWM, AS, CC 
10 Burn E, et al. BMJ Open 2018;8:e019146. doi:10.1136/bmjopen-2017-019146
Open Access 
and NKA revising it for important intellectual content. All authors read and approved 
the final manuscript.
Funding DPA is funded by a National Institute for Health Research Clinician 
Scientist award (CS-2013-371 13-012). This work was supported by the NIHR 
Biomedical Research Centre, Oxford. 
Disclaimer This article presents independent research funded by the National 
Institute for Health Research (NIHR). The views expressed are those of the authors 
and not necessarily those of the NHS, the NIHR or the Department of Health.
Competing interests All authors have completed the ICMJE uniform disclosure 
form at www. icmje. org/ coi_ disclosure. pdf and declare that NKA has received 
personal fees from Freshfields Bruckhaus Deringer, Bioventus, Flexion, Merck 
and Regeneron, all outside the submitted work. DPA reports grants from Amgen, 
Servier and UCB Biopharma, and non-financial support from Amgen, all outside the 
submitted work. DWM reports grants and personal fees from Zimmer Biomet. In 
addition, DWM has various patents related to Unicompartmental Knee Replacement 
(Zimmer Biomet) with royalties paid. 
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement CPRD data with HES linkage were provided under a 
licence that does not permit sharing. Data are obtainable from CPRD subject to a 
full application.
Open Access This is an Open Access article distributed in accordance with the 
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits 
others to distribute, remix, adapt and build upon this work, for commercial use, 
provided the original work is properly cited. See: http:// creativecommons. org/ 
licenses/ by/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
reFerenCes
 1. Pivec R, Johnson AJ, Mears SC, et al. Hip arthroplasty. Lancet 
2012;380:1768–77.
 2. Carr AJ, Robertsson O, Graves S, et al. Knee replacement. Lancet 
2012;379:1331–40.
 3. Culliford DJ, Maskell J, Beard DJ, et al. Temporal trends in hip and 
knee replacement in the United Kingdom: 1991 to 2006. J Bone Joint 
Surg Br 2010;92-B:130–5.
 4. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip 
and knee arthroplasty in the United States from 2005 to 2030.  
J Bone Joint Surg Am 2007;89:780–5.
 5. Cram P, Lu X, Kates SL, et al. Total knee arthroplasty volume, 
utilization, and outcomes among Medicare beneficiaries, 1991–2010. 
JAMA 2012;308:1227.
 6. Smith ID, Elton R, Ballantyne JA, et al. Pre-operative predictors of 
the length of hospital stay in total knee replacement. J Bone Joint 
Surg Br 2008;90:1435–40.
 7. Cram P, Lu X, Kaboli PJ, et al. Clinical characteristics and outcomes 
of Medicare patients undergoing total hip arthroplasty, 1991–2008. 
JAMA 2011;305:1560.
 8. Cookson R, Laudicella M. Do the poor cost much more? The 
relationship between small area income deprivation and length of 
stay for elective hip replacement in the English NHS from 2001 to 
2008. Soc Sci Med 2011;72:173–84.
 9. Husted H, Jensen CM, Solgaard S, et al. Reduced length of 
stay following hip and knee arthroplasty in Denmark 2000–2009: 
from research to implementation. Arch Orthop Trauma Surg 
2012;132:101–4.
 10. Jimenez-Garcıa R, Villanueva-Martınez M, Fernandez-de-Las-Penas 
C, et al. Trends in primary total hip arthroplasty in Spain from 2001 to 
2008: evaluating changes in demographics, comorbidity, incidence 
rates, length of stay, costs and mortality. BMC Musculoskelet Disord 
2011;12:43.
 11. Pamilo KJ, Peltola M, Mäkelä K, et al. Is hospital volume associated 
with length of stay, re-admissions and reoperations for total 
hip replacement? A population-based register analysis of 78 
hospitals and 54,505 replacements. Arch Orthop Trauma Surg 
2013;133:1747–55.
 12. Herrett E, Gallagher AM, Bhaskaran K, et al. Data Resource 
Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 
2015;44:827–36.
 13. Herbert A, Wijlaars L, Zylbersztejn A, et al. Data Resource Profile: 
Hospital Episode Statistics Admitted Patient Care (HES APC). Int J 
Epidemiol 2017;10:1.
 14. Armitage JN, van der Meulen JH; Royal College of Surgeons Co-
morbidity Consensus Group. Identifying co-morbidity in surgical 
patients using administrative data with the Royal College of 
Surgeons Charlson Score. Br J Surg 2010;97:772–81.
 15. Siciliani L, Sivey P, Street A. Differences in length of stay for hip 
replacement between public hospitals, specialised treatment 
centres and private providers: selection or efficiency? Health Econ 
2013;22:234–42.
 16. Mihaylova B, Briggs A, O'Hagan A, et al. Review of statistical 
methods for analysing healthcare resources and costs. Health Econ 
2011;20:897–916.
 17. Aho K, Derryberry D, Peterson T. Model selection for ecologists: the 
worldviews of AIC and BIC. Ecology 2014;95:631–6.
 18. R Core Team. R: a language and environment for statistical 
computing. Vienna, Austria: R Foundation for Statistical Computing, 
2016.
 19. Wickham H, Francois R. dplyr: a grammar of data manipulation. R 
package version 0.5.0. 2016.
 20. Harrell FE. rms: regression modeling strategies. R package version 
5.1-0. 2017.
 21. Wickham H. ggplot2: elegant graphics for data analysis. New York: 
Springer-Verlag, 2009.
 22. Kehlet H. Fast-track hip and knee arthroplasty. Lancet 
2013;381:1600–2.
 23. Maempel JF, Walmsley PJ. Enhanced recovery programmes 
can reduce length of stay after total knee replacement without 
sacrificing functional outcome at one year. Ann R Coll Surg Engl 
2015;97:563–7.
 24. Paton F, Chambers D, Wilson P, et al. Effectiveness and 
implementation of enhanced recovery after surgery programmes: a 
rapid evidence synthesis. BMJ Open 2014;4:e005015.
 25. Khan SK, Malviya A, Muller SD, et al. Reduced short-term 
complications and mortality following enhanced recovery primary hip 
and knee arthroplasty: results from 6,000 consecutive procedures. 
Acta Orthop 2014;85:26–31.
 26. Jones EL, Wainwright TW, Foster JD, et al. A systematic review of 
patient reported outcomes and patient experience in enhanced 
recovery after orthopaedic surgery. Ann R Coll Surg Engl 
2014;96:89–94.
 27. Husted H, Otte KS, Kristensen BB, et al. Readmissions after 
fast-track hip and knee arthroplasty. Arch Orthop Trauma Surg 
2010;130:1185–91.
 28. Starks I, Wainwright TW, Lewis J, et al. Older patients have the most 
to gain from orthopaedic enhanced recovery programmes. Age 
Ageing 2014;43:642–8.
 29. Cary MP, Baernholdt M, Merwin EI. Changes in payment regulation 
and acute care use for total hip replacement: trends in length of stay, 
costs, and discharge, 1997-2012. Rehabil Nurs 2016;41:67–77.
 30. Molloy IB, Martin BI, Moschetti WE, et al. Effects of the length of 
stay on the cost of total knee and total hip arthroplasty from 2002 to 
2013. J Bone Joint Surg Am 2017;99:402–7.
 31. El Bitar YF, Illingworth KD, Scaife SL, et al. Hospital length of stay 
following primary total knee arthroplasty: data from the nationwide 
inpatient sample database. J Arthroplasty 2015;30:1710–5.
 32. Shah AN, Vail TP, Taylor D, et al. Comorbid illness affects hospital 
costs related to hip arthroplasty: quantification of health status and 
implications for fair reimbursement and surgeon comparisons. J 
Arthroplasty 2004;19:700–5.
 33. Harty L, O'Toole G, FitzGerald O. Profound reduction in hospital 
admissions and musculoskeletal surgical procedures for rheumatoid 
arthritis with concurrent changes in clinical practice (1995–2010). 
Rheumatology 2015;54:666–71.
 34. Thomas SL, Edwards CJ, Smeeth L, et al. How accurate are 
diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis 
in the general practice research database? Arthritis Rheum 
2008;59:1314–21.
 35. Hawley S, Delmestri A, Judge A, et al. Total hip and knee 
replacement among incident osteoarthritis and rheumatoid arthritis 
patients within the UK Clinical Practice Research Datalink (CPRD) 
compared to Hospital Episode Statistics (HES): a validation study. 
Pharmacoepidemiol Drug Saf 2016.
